RxDoctor Payments Data

Vatsal Patel, DO

Internal Medicine · Evanston, ILNPI 1639458763

Payments from drug & device makers

$1,060in general payments, 2019–2025

Across 21 payments — averaging $50.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$239
  • Medtronic$197
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$133
  • Intuitive Surgical$127
  • Novo Nordisk$125
  • Biohaven Pharmaceutical Holding Company Ltd.$116
  • plus $123 from 3 others

What the payments were for

  • Food & beverage$1,060100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,060 in reported general payments places this provider in the 75th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$218,005
Medicare patients
308
Services billed
2,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$17,152
XareltoRivaroxaban40$13,665
RexultiBrexpiprazole15$11,225
EntrestoSacubitril/Valsartan26$10,441
TradjentaLinagliptin14$6,255
Memantine Hcl28$2,630
Atorvastatin Calcium100$1,716
Incruse ElliptaUmeclidinium Bromide12$1,431
Omeprazole57$1,014
Donepezil Hcl57$991
Sertraline Hcl58$887
Midodrine Hcl11$884
Pantoprazole Sodium76$695
Hydralazine Hcl36$649
ClopidogrelClopidogrel Bisulfate42$639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$239$13,66540 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Evanston

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →